Regencell Bioscience Holdings (RGC) Shareholder's Equity (2020 - 2025)

Regencell Bioscience Holdings (RGC) Shareholder's Equity (2020 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shareholder's Equity (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	8.23 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	3.23 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	5.90 Bn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	407.18 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	3.41 Bn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	6.50 Bn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	1.75 Bn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	446.17 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	1.21 Bn
10	Regencell Bioscience Holdings	-	-	-	1.22 Mn

Download Data